Study Reveals Link Between Xarelto Use and Serious Liver Injury

Gabriel A. Assaad
Partner Gabriel Assaad represents victims of negligence and medical malpractice nationwide.
Comments (0)

Since 2011, the U.S. Food and Drug Administration (FDA) has approved the use of the medication Xarelto to thin the blood and reduce the risk of stroke and other cardiovascular issues. Unfortunately, as time passes, the use of the drug has been linked with more and more adverse side effects. A recent study is now discussing the link between use of the drug and severe liver damage.

6 Tips About the Link Between Xarelto and Liver Damage

Interested in learning more about the use of Xarelto and liver damage? The following is an overview:

  • A recent case study published in the medical journal JAMA Internal Medicine reviewed the cases of two patients taking Xarelto who ultimately suffered liver injury.
  • The first patient was a 52-year-old man who developed severe liver injury two months after taking Xarelto. He took the drug to prevent deep vein thrombosis after suffering an internal fixation of a tibia fracture.
  • The second patient was a 73-year-old woman who was taking 10 milligrams of Xarelto per day after having a total knee replacement. This woman similarly suffered a severe liver injury.
  • The researchers concluded that the two liver injuries were most likely caused by the use of Xarelto.
  • The researchers further concluded that both patients and physicians should be aware of this potentially severe adverse reaction to the drug.
  • In addition, the researchers recommended that a warning be added to the drug’s label regarding the risk of symptomatic liver injury.

If you or a loved one took Xarelto and suffered injuries as a result, you may be entitled to compensation. We are here to help. We encourage you to reach out today for a free consultation at 855-947-0707.

 

Be the first to comment!

Post a Comment

To reply to this message, enter your reply in the box labeled "Message", hit "Post Message."

Name:*

Email:* (will not be published)

Message:*

Notify me of follow-up comments via email.